On January 20, 2026, Weill Cornell Medicine will host a seminar focusing on the role of cyclic adenosine monophosphate (cAMP) in sperm motility and its implications for developing targeted contraceptives. Led by Carla Ritagliati, Ph.D., an instructor in the Department of Pharmacology, this event aims to explore innovative approaches to contraception through a deeper understanding of sperm function.
The seminar, titled “The Role of cAMP in Sperm Motility as the Basis for sAC-Targeting Contraceptives,” will take place from 4:00 PM to 5:00 PM at the Anne Evans Estabrook Lecture Hall, located at 1300 York Avenue in New York, N.Y.. This presentation is part of a series hosted by faculty members Dr. Jochen Buck and Dr. Lonny Levin, who are leading figures in pharmacology research.
Understanding the mechanisms behind sperm motility is crucial for creating new contraceptive options. Dr. Ritagliati’s research focuses on the enzyme soluble adenylyl cyclase (sAC), which plays a significant role in the regulation of sperm movement through cAMP signaling pathways. This research could pave the way for novel contraceptive methods that selectively target these pathways.
The seminar promises to be an engaging discussion for both scientists and those interested in reproductive health. Attendees will have the opportunity to gain insights into cutting-edge research that could influence future contraceptive technologies.
Attendance is open to the public, and those interested in reproductive health, pharmacology, or related fields are encouraged to participate. This event represents a significant opportunity to learn about the intersection of basic science and practical applications in the field of contraception.
For more information about the seminar, including registration details, visit the official Weill Cornell Medicine events page at https://events.weill.cornell.edu/event/the-role-of-camp-in-sperm-motility-as-the….
